- Home
- TALK vs BBNX Comparison
TALK vs BBNX Comparison
Compare TALK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TALK | BBNX |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | 409 |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 656.0M | 610.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TALK | BBNX |
|---|---|---|
| Price | $4.50 | $13.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $5.90 | ★ $26.73 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.10 | $35.03 |
| Revenue Next Year | $18.15 | $33.24 |
| P/E Ratio | $155.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.22 | $8.89 |
| 52 Week High | $5.18 | $32.71 |
Technical Indicators
Market Signals| Indicator | TALK | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 33.21 |
| Support Level | $2.52 | $12.48 |
| Resistance Level | N/A | $15.64 |
| Average True Range (ATR) | 0.27 | 1.17 |
| MACD | 0.07 | 0.46 |
| Stochastic Oscillator | 50.67 | 52.02 |
Price Performance
Historical ComparisonAbout TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.